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1) 制备了载羟基喜树碱聚乳酸纳米粒：以 HCPT-PLA 纳米粒粒径(符合静脉
注射要求≈200nm)和载药率为评价标准，通过正交实验设计 L9(33)考察 D,L-PLA
浓度、HCPT 与 PLA 质量比及不同截留分子量(MWCO)透析袋对其指标的影响；
确定了 HCPT-PLA 纳米粒的 佳工艺：即室温条件下以 N,N-二甲基甲酰胺
（DMF）为溶剂，PLA 浓度为 2 mg/mL，HCPT 与 PLA 质量比为 1:5，截留分子
量为 3500 的透析袋，透析时间为 10 h；                                                 
2) 进行了 HCPT-PLA 纳米粒的表征：用动态光衍射(DLS)、扫描电镜(SEM)、
透射电镜(TEM)、原子力显微镜(AFM)、紫外光谱分析(UV)、激光共聚焦显微镜
(CLSM)、粉末 X-射线衍射仪(XRD)和差示扫描量热仪(DSC)对 HCPT-PLA 纳米
粒的粒径、稳定性、形态及状态进行了鉴定，结果表明 HCPT-PLA 纳米粒为表
面圆滑的实心球体，药物以晶体状态均匀分布于聚乳酸纳米粒中； 
3) 考察了 HCPT-PLA 纳米粒的体外释药性能：药物的释放速率有明显 pH
值依赖性，pH 值越高，药物释放速度越快且释药曲线符合 Huguichi 方程； 
4) MTT 试验检测了细胞毒作用：体外细胞培养实验采用人肝癌细胞
(BEL-7402)，MTT 结果显示，空白 PLA 纳米粒对该细胞无细胞毒作用，对比空















果显示，纯 HCPT 及 HCPT-PLA 纳米粒均具有明显浓度依赖性细胞毒作用且
HCPT-PLA 纳米粒的生长抑制率略高于纯 HCPT。 
5) 体内抑瘤率试验：以 H22 肝癌实体瘤的昆明雄性小鼠为实验模型，通过
尾静脉注射方式考察 HCPT-PLA 纳米粒体内抑瘤效果。结果显示：HCPT-PLA 纳
米粒在体内具有较好的抑瘤活性且抑瘤效果高于同剂量的纯 HCPT。抑瘤效果无
明显的量效关系。 









































Dialysis method was developed to prepare polymer particles in recent years. 
Dialysis method is an acceptably simple and effective method for preparation particles 
without the additional surfactants, which is expected to apply in industrial production.  
10-hydroxycamptothecin (HCPT) is a promising broad-spectrum antitumor agent 
that targets the nuclear enzyme topoisomerase I and has achieved remarkable success 
in early clinical trials. However, the clinical application of HCPT was largely 
hampered because of its poor solubility and stability, which led to low therapeutic 
efficiency and a number of side effects to normal tissues such as neutropenia, 
thrombocytopenia, and diarrhea owing to the conversion of HCPT from active lactone 
form to the inactive carboxylate form under physiologic conditions. Therefore, 
finding suitable formulations for the delivery of the HCPT is of great significance in 
fully unleashing the potential of HCPT drug. 
The contents are summarized as follows:  
1) Preparation of HCPT-loaded PLA nanoparticles: in this work, our aim was 
to obtain the nanoparticles of desired size range (about 200 nm) and highest 
drug-loading content. For this purpose, an orthogonal L9 (33) test design was used to 
investigate the optimal formulation condition. The analysis results of orthogonal test 
performed by statistical software SPSS 13.0 are presented as follow: organic solvent: 
DMF; PLA concentration: 2 mg/mL; the ratio of HCPT to PLA: 1:5 (wt/wt); dialysis 
bag: MWCO 3500, time: 10 h. 
2) Physicochemical characterizations of HCPT-loaded PLA nanoparticles: 
the obtained HCPT-PLA nanoparticles were characterized by dynamic light scattering 
(DLS), scanning electron microscopy (SEM)/transmission electron microscopy 
(TEM), atomic force microscopy (AFM), X-ray diffraction (XRD), differential 
scanning calorimetry (DSC) and confocal laser scanning fluorescence microscope 
(CLSFM). Based on these experimental results, it was proposed that the distribution 
of HCPT in PLA nanoparticles was very uniform and HCPT was a crystalline state 
existed in PLA nanoparticles. 
3) In vitro release studies: It is worth noting that there was no obvious burst 
effect of HCPT releasing from the PLA nanoparticles and the release profiles show 















nanparticles. The mean in vitro cumulative release percentage of HCPT from 
HCPT-loaded PLA nanoparticles vs. time curve fitted well with the Higuchi Equation. 
4) In vitro cytotoxicity assay: Cytotoxicity test indicated that the HCPT-loaded 
PLA nanoparticles had enhanced in vitro cytotoxicity against human liver BEL-7402 
cells compared to the commercially available HCPT injection and it was obvious that 
the growth-inhibitory effect was concentration dependent. 
5) In vivo antitumor effect in H22 bearing KunMing male mice: the in vivo 
antitumor effect in H22-bearing KM male mice after i.v. injection of the HCPT-loaded 
PLA nanoparticles showed that the HCPT-loaded PLA nanoparticles exhibited 
superior antitumor effect compared to the free HCPT. 
These obtained results are promising for preparing nanoparticles for entrapping 
HCPT, which emphasize the potential of HCPT-loaded biodegradable nanoparticles 
for cancer chemotherapy. 
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